BeOne Medicines Ltd.

NASDAQ: ONC · Real-Time Price · USD
309.33
-3.18 (-1.02%)
At close: Aug 20, 2025, 3:59 PM
309.00
-0.11%
After-hours: Aug 20, 2025, 07:53 PM EDT

BeOne Medicines Revenue

BeOne Medicines reported an annual revenue of $3.81B, reflecting a 54.96% growth. For the quarter ending June 30, 2025, BeOne Medicines generated $1.32B in revenue.
Revenue (ttm)
3.81B
Revenue Growth
54.96%
Price / Sales Ratio
5.1
Revenue / Employee
346.39K
Employees
11,000
Market Cap
33.05B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 3.81B +54.96%
Dec 31, 2023 2.46B +73.65%
Dec 31, 2022 1.42B +20.37%
Dec 31, 2021 1.18B +280.83%
Dec 31, 2020 308.87M -27.87%
Dec 31, 2019 428.21M +116.03%
Dec 31, 2018 198.22M -16.85%
Dec 31, 2017 238.39M +22179.16%
Dec 31, 2016 1.07M -87.86%
Dec 31, 2015 8.82M -32.37%
Dec 31, 2014 13.04M +16.93%
Dec 31, 2013 11.15M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.